LDS/Medical Tests/Testosterone, Free

Testosterone, Free

Testosterone is a naturally occurring, androgenic hormone that originates from the testes in males and the ovaries in females. Free testosterone is known to be the “active” testosterone due to the fact that the majority of testosterone is bound to plasma proteins such as albumin, sex hormone binding globulin, and cortisol binding globulin. Measuring free testosterone is found to be the most clinically significant because the amount of bound testosterone is affected by the levels of the proteins available for transport. The effects of testosterone are seen mostly in men but are important in women as well. Free testosterone influences sex drive, muscle mass, energy levels, bone density, red blood cell production, and tissue repair. Men with decreased testosterone or hypogonadism may need to receive testosterone therapy to increase libido, prevent depression, cardiovascular disease, and osteoporosis. In females, increased serum testosterone levels may be indicative of polycystic ovary syndrome and adrenal hyperplasia. The clinical manifestations of excess testosterone include infertility, hirsutism (excessive hairiness), amenorrhea (lack of menstruation), and obesity. The free testosterone test can be used for monitoring testosterone therapy.

  • Diagnosis of hypogonadism in males and hirsutism and virilization in females
  • Diagnosis of androgen-secreting tumors
  • Evaluating delayed puberty or precociousness
  • Evaluation of LH secretion and Leydig cell function
  • Evaluation of gonadal and adrenal function
  • As an aid in diagnosis of infertility (men and women)
  • Hormone (testosterone) therapy monitoring in postmenopausal women

Increased in:

  • Idiopathic sexual precocity (in boys, levels may be in adult range)
  • Polycystic ovary syndrome (in females)
  • Adrenal hyperplasia
  • Adrenocortical tumors
  • Trophoblastic disease during pregnancy
  • Idiopathic hirsutism
  • Virilizing ovarian tumors
  • Arrhenoblastoma
  • Virilizing luteoma
  • Liver cirrhosis (through increased SHBG)
  • Hyperthyroidism
  • Some drugs such as anticonvulsants, barbiturates, estrogens, oral contraceptives (through increased SHBG)

Decreased in:

  • Hypogonadism
  • Orchiectomy
  • Klinefelter’s syndrome
  • Liver insufficiency
  • Some drugs: digoxin, spironolactone, acarbose

Note: the diagnosis of male hypogonadism is based on clinical symptoms and signs plus laboratory confirmation of low morning total serum testosterone levels on two different occasions. In addition to free testosterone and total testosterone levels, serum luteinizing hormone and FSH levels should be obtained to distinguish between primary (hypergonadotropic) and secondary (hypogonadotropic) hypogonadism. Hypogonadism associated with aging (andropause) may present a mixed picture, with low testosterone levels and low to low-normal gonadotropin levels.

Group pg/mL pmol/L
Cord
Male 5–22 17.2–76.3
Female 4–16 13.9–55.5
Newborn
1–15 days, Male 1.5–31.0 5.2–107.5
1–15 days, Female 0.5–2.5 1.7–8.7
1–3 mo, Male 3.3–8.0 11.5–62.5
1–3 mo, Female 0.1–1.3 0.3–4.5
3–5 mo, Male 0.7–14.0 2.4–48.6
3–5 mo, Female 0.3–1.1 1.0–3.8
5–7 mo, Male 0.4–4.8 1.4–16.6
5–7 mo, Female 0.2–0.6 0.7–2.1
Children
6–9 yr, Male 0.1–3.2 0.3–1.1
6–9 yr, Female 0.1–0.9 0.3–3.1
10–11 yr, Male 0.6–5.7 2.1–19.8
10–11 yr, Female 1.0–5.2 3.5–18.0
12–14 yr, Male 1.4–156 4.9–541
12–14 yr, Female 1.5–5.2 3.5–18.0
15–17 yr, Male 80–159 278–552
15–17 yr, Female 1.0–5.2 3.5–18.0
Adult
Male 50–210 174–729
Female 1.0–8.5 3.2–29.5
Quantitative homogeneous fluorescent-based microparticles immunoassay using flow cytometry readings (bead multiplexing immunoassay), Radioimmunoassay, Liquid chromatography Mass Spectrometry (LC/MS).

Serum (SST).

Stability

  • Ambient: 5-7 days
  • Refrigerated: 7-14 days
  • Frozen: 24 months
FSH, LH, Sex Binding Globulin, Cortisol Binding Globulin, Estrogen, Total Testosterone, Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Aldosterone, Vitamin D-25OH, Cortisol, Dyhydroepiandrosterone, Dihydrotestosterone, Inhibin A, Calcium, Complete Semen Analysis.
Usually 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Clin Endocrinol Metab. 2012 Jan;97(1):179-89. [PMID: 22013106]
  • Ann Clin Biochem. 2006 Jan;43(Pt 1):3-12. [PMID: 16390603]
  • Front Horm Res. 2009;37:21-31. [PMID: 19011286]
  • Methods Mol Biol. 2006;324:197-211. [PMID: 16761380]
  • Ann Clin Biochem. 1995 Jul;32 ( Pt 4):345-57. [PMID: 7486793]
  • Ann Clin Biochem. 2006;43(Pt 1):3. [PMID: 16390603] B
  • est Pract Res Clin Endocrinol Metab. 2006;20:177. [PMID: 16772150] Testosterone. In Mosby's Dictionary of Medicine, Nursing and Health Professions, 8th Edition (p. 654). St. Louis: Mosby Elsevier (2009).
  • Diagnostics Biochem Canada Inc. package insert Free Testosterone Version 3.1, September 2007
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
  • Sandhya Pruthi M. (2008, July 20). Menopause. Retrieved July 10, 2010, from Mayo Clinic.com: http://www.mayoclinic.com/health/testosterone-therapy/AN01390